Safety and Pharmacokinetics of PATANASE in Paediatric Patients 2 to < 6 Years of Age with a history of allergic rhinitis
Phase of Trial: Phase II
Latest Information Update: 27 Nov 2017
At a glance
- Drugs Olopatadine (Primary)
- Indications Allergic rhinitis
- Focus Adverse reactions
- Sponsors Alcon
- 02 Mar 2010 Results presented at the 66th Annual Meeting of the American Academy of Allergy, Asthma and Immunology
- 05 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Dec 2009 Status changed from recruiting to active, no longer recruiting.